Delivery Order SPE2DB22D2206-SPE2DB25FJA32
- Not listed
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.30 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 4, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply chain requirements. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,495.03 to AmerisourceBergen Drug Corp for Omnipod 5 Dexcom G7 Generation 5 insulin infusion pods. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 24, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods valued at $1,222.32. This competitive, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,222.32 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pump pods on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.48 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed price pricing and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical supply...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for OmniPod 5 Dexcom G7 generation 5 insulin infusion pump pods. This $32,078.67 firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. The products will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,804.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. This non-set-aside competitive award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA32Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,182.82 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies the Defense Logistics Agency with an extensive portfolio of pharmaceutical products and medical devices across multiple therapeutic domains. As a leading healthcare solutions provider, the company fulfills federal medical supply needs through its expansive IDC with DLA, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies supporting military and veteran healthcare systems worldwide. This delivery order for insulin pump pods reflects the company's continued role in supplying specialized diabetes management devices to support the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/22/25 |